TradingKey

• Brent crude futures declined as Middle Eastern export flows recovered toward pre-disruption levels. • Strategic reserve releases and strong US dollar weighed on dollar-denominated energy commodities. • Technical indicators show neutral MACD and RSI, with Williams %R suggesting a sell condition.

• Brent crude prices retreated due to eased supply bottlenecks and geopolitical risk reductions. • Demand destruction concerns and institutional profit-taking reinforced the recent price pullback. • Technical indicators including MACD, RSI, and Williams %R all show neutral signals.

• WTI crude futures fell due to unexpected U.S. inventory builds and profit-taking. • High domestic production and geopolitical risks created contrasting forces in energy markets. • Technical indicators show neutral conditions with the Williams %R signaling oversold levels.

• Middle Eastern seaborne crude exports recovered, easing physical supply constraint fears. • US commercial crude inventories unexpectedly increased while domestic production remained near records. • Technical indicators show WTI in neutral to oversold market conditions.

• Ethereum rose due to positive risk sentiment and macroeconomic factors. • Institutional demand through regulated products reinforced underlying structural support. • Network fundamentals and tight supply dynamics bolstered investor confidence.

• XRP gains were driven by macroeconomic relief and institutional capital inflows. • On-chain exchange outflows and protocol upgrades reinforced fundamental network backing. • Technical indicators like MACD, RSI, and Williams %R remain neutral.

TradingKey - After experiencing a noticeable pullback in the first half of 2026, Palantir's (PLTR) stock price has rebounded rapidly over the past few months.

• Lower inflation metrics boosted risk appetite and Federal Reserve monetary easing expectations. • Spot Bitcoin ETF allocations and corporate accumulation drove strong institutional demand. • Technical indicators like the RSI and Williams %R suggested neutral to buying conditions.

TradingKey - On September 28, Eastern Time, Nvidia (NVDA) shares bucked the trend and gained amid broader pressure on technology stocks, driven primarily by its newly announced massive stock buyback plan. On September 28, Nvidia announced that its board of directors approved an additional $150 billion for its existing share repurchase authorization, bringing the remaining buyback capacity to $235 billion. The company plans to execute the program by the end of fiscal year 2028, marking the largest buyback in U.S. stock market history. Following the announcement, Nvidia rose 1.68% on the day to close at $228.86, touching an intraday high of $233.21, while the Nasdaq Index fell 0.92% over the same period, demonstrating that the buyback news provided clear independent support for the stock.

• Solana advanced due to persistent institutional capital inflows via regulated spot exchange-traded funds. • On-chain data indicates elevated trading volumes and expansion in stablecoin issuer integration. • Technical indicators show a neutral MACD, neutral RSI, and a buy Williams %R.

Acuity’s fiscal Q4 sales rose 2.9% and adjusted EPS gained 11% as Intelligent Spaces growth offset weaker lighting profitability.

Accenture reported 7% local-currency revenue growth in fiscal Q4 2026 and forecast 3% to 6% growth for FY2027, with further margin expansion.

In September 2026, Nvidia retained its top spot globally with a market capitalization of $5.56 trillion, followed closely by Apple, Alphabet (Class A), and Microsoft. Meta Platforms saw the largest shift in the September global market cap rankings: the company surged 29%, pushing its market cap to $1.88 trillion and overtaking Broadcom to rank eighth. The Philadelphia Semiconductor Index rose 9.1% in September, accelerating noticeably from a 1.98% gain in August. However, internal divergence within the index persisted, with TSMC, SK Hynix, and Micron Technology strengthening while Broadcom fell 4.3%.

NIKE Q1 fiscal 2027 revenue fell 4% to $11.2 billion. Management expects a high-single-digit FY27 revenue decline and adjusted EPS of $1.15-$1.35.

• Amgen faced intraday downward pressure and profit-taking after rallying to multi-year highs. • Core commercial volume growth remained strong alongside ongoing headwinds from biosimilar competition. • Technical indicators show a neutral MACD of 5.033 and an RSI of 50.194.

• Salesforce shares rose following positive developments in enterprise artificial intelligence strategies. • Wall Street analysts highlighted resilient IT spending and strong Agentforce adoption trends. • The company reported $41.52B in annual revenue and $7.46B in net profit.

• Rising U.S. Treasury yields and macroeconomic headwinds pressured Thermo Fisher Scientific's stock. • Premium historical valuations prompted institutional investors to take profits and reduce exposure. • Annual revenue reached $44.56 billion with net profit at $6.70 billion.

• Micron beat fourth-quarter estimates and issued strong first-quarter guidance. • Multi-year customer commitments secure production capacity through 2027. • Analysts raised price targets following robust artificial intelligence-driven demand.

• Boeing secured a massive U.S. Navy defense contract exceeding twenty billion dollars. • Regulatory reviews regarding 737 MAX software issues caused notable intraday trading volatility. • Analysts maintain an average price target of $268.79 with a buy rating.

Accenture’s fiscal Q4 2026 revenue rose 7% in local currency to $18.7 billion. Review bookings, AI demand, margins and fiscal 2027 guidance.